Regurgitates is an appropriate word for your saying nothing but repeating the graphs and outlooks from Mayne leadership. I will repeat from memory August 2019 they signed agreement with Mithra to purchase distribution rights USA . The outlook was although this will be costing $500M + we will have revenue of $200M within 4 years. The simple facts it has cost us our Plant in Nth Carolina. We have employed and trained and continue to employ at huge expense 100 sales representatives across the US. With the product being in the market place for 3 years plus . Iurs $30m revenue atm is in anyone’s eyes a dismal failure. Yet it is still being held up as this saviour. Just do a quick analysis in comparison to some Dermatology products. God man where would we be without Derm.? Anyway the current SP says it all not your repeating what our illustrious executives are spruiking. Believe me man they are taking care of themselves first and foremost. That is why they don’t buy shares . Of course I am frustrated I admit that because I once was a fool just like you.
MYX Price at posting:
$4.62 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)